BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 14576104)

  • 1. RhoA suppresses pseudorabies virus replication in vitro.
    Li XM; Wang SP; Wang JY; Tang T; Wan B; Zeng L; Wang J; Chu BB; Yang GY; Pan JJ
    Virol J; 2023 Nov; 20(1):264. PubMed ID: 37968757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State.
    Shtro AA; Petukhova GD; Romanova AS
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Selection and Evaluation of Pugnins with Antibacterial and Anticancer Activity Using Skin Transcriptome of Treefrog (
    Liscano Y; Medina L; Oñate-Garzón J; Gúzman F; Pickholz M; Delgado JP
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33919639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2.
    Liscano Y; Oñate-Garzón J; Ocampo-Ibáñez ID
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and expression of a RhoA peptide against respiratory syncytial virus infection in plants.
    Ortega-Berlanga B; Musiychuk K; Shoji Y; Chichester JA; Yusibov V; Patiño-Rodríguez O; Noyola DE; Alpuche-Solís ÁG
    Planta; 2016 Feb; 243(2):451-8. PubMed ID: 26474991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.
    Espinoza JA; Bueno SM; Riedel CA; Kalergis AM
    Immunology; 2014 Sep; 143(1):1-12. PubMed ID: 24801878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects For the Use of Peptides against Respiratory Syncytial Virus].
    Shilovskiy IP; Andreev SM; Kozhikhova KV; Nikolskii AA; Khaitov MR
    Mol Biol (Mosk); 2019; 53(4):541-560. PubMed ID: 31397431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.
    Budge PJ; Lebowitz J; Graham BS
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3470-7. PubMed ID: 14576104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
    Budge PJ; Graham BS
    J Antimicrob Chemother; 2004 Aug; 54(2):299-302. PubMed ID: 15254023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.
    Budge PJ; Li Y; Beeler JA; Graham BS
    J Virol; 2004 May; 78(10):5015-22. PubMed ID: 15113882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.
    Pastey MK; Gower TL; Spearman PW; Crowe JE; Graham BS
    Nat Med; 2000 Jan; 6(1):35-40. PubMed ID: 10613821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Gaillard V; Galloux M; Garcin D; Eléouët JF; Le Goffic R; Larcher T; Rameix-Welti MA; Boukadiri A; Héritier J; Segura JM; Baechler E; Arrell M; Mottet-Osman G; Nyanguile O
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and dendrimeric antiviral peptides: design, chemical synthesis and activity against human respiratory syncytial virus.
    Kozhikhova KV; Shilovskiy IP; Shatilov AA; Timofeeva AV; Turetskiy EA; Vishniakova LI; Nikolskii AA; Barvinskaya ED; Karthikeyan S; Smirnov VV; Kudlay DA; Andreev SM; Khaitov MR
    J Mater Chem B; 2020 Apr; 8(13):2607-2617. PubMed ID: 32124885
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.